EcoDrugPlus

Glutamate Ionotropic Receptor Kainate Type Subunit 5

Ensembl ID : ENSSAUG00010003187
Gene Symbol: GRIK5
1 Cross references
229 Possible Orthologues:

Glutamate Metabotropic Receptor 2

Ensembl ID : ENSSAUG00010005874
Gene Symbol: GRM2
3 Cross references
206 Possible Orthologues:

Glutamate Metabotropic Receptor 4

Ensembl ID : ENSSAUG00010026332
Gene Symbol: GRM4
3 Cross references
207 Possible Orthologues:

Glutamate Metabotropic Receptor 4

Ensembl ID : ENSSAUG00010004196
Gene Symbol: GRM4
3 Cross references
196 Possible Orthologues:

Glutamate Metabotropic Receptor 5

Ensembl ID : ENSSAUG00010007984
Gene Symbol: GRM5
3 Cross references
216 Possible Orthologues:

Glutamate Receptor 1-Like

Ensembl ID : ENSSAUG00010001582
Gene Symbol: LOC115593585
3 Cross references
249 Possible Orthologues:

Glutamate Receptor 2-Like

Ensembl ID : ENSSAUG00010012962
Gene Symbol: LOC115591152
3 Cross references
242 Possible Orthologues:

Glutamate Receptor 3-Like

Ensembl ID : ENSSAUG00010026393
Gene Symbol: LOC115593926
3 Cross references
251 Possible Orthologues:

Glutamate Receptor 4

Ensembl ID : ENSSAUG00010003244
Gene Symbol: LOC115593451
3 Cross references
249 Possible Orthologues:

Glutamate Receptor Ionotropic, Nmda 2a-Like

Ensembl ID : ENSSAUG00010002933
Gene Symbol: LOC115586915
2 Cross references
98 Possible Orthologues:

Glutamate Receptor Ionotropic, Nmda 2d-Like

Ensembl ID : ENSSAUG00010020231
Gene Symbol: LOC115579192
2 Cross references
214 Possible Orthologues:

Glutamate Receptor Ionotropic, Nmda 3b-Like

Ensembl ID : ENSSAUG00010026598
Gene Symbol: LOC115566295
2 Cross references
226 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).